These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8081136)

  • 1. Multiple primary melanoma: risk factors and prognostic implications.
    Burden AD; Vestey JP; Sirel JM; Aitchison TC; Hunter JA; MacKie RM
    BMJ; 1994 Aug; 309(6951):375. PubMed ID: 8081136
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of patients with multiple primary melanomas.
    Adler NR; Kelly JW; Haydon A; McLean CA; Mar VJ
    Br J Dermatol; 2018 Jan; 178(1):e44-e45. PubMed ID: 28755438
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced survival in patients with multiple primary melanoma.
    Doubrovsky A; Menzies SW
    Arch Dermatol; 2003 Aug; 139(8):1013-8. PubMed ID: 12925389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple primary malignancies and prolonged survival in a patient with widespread metastatic cutaneous melanoma.
    Rose AM; Radia UK; Luo R; Kalirai H; Jayasena CN; Luthert P; Coupland SE; Rose GE
    Melanoma Res; 2018 Apr; 28(2):163-166. PubMed ID: 29346178
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased cancer mortality following a history of nonmelanoma skin cancer.
    Moore M
    J Insur Med; 1998; 30(3):202-3. PubMed ID: 10351183
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant melanoma in Scotland: trends in incidence and survival, 1968-87. A review prepared by the CSA Information and Statistics Division for the Health Monitoring Group.
    Black RJ; Clarke JA; Warner JM
    Health Bull (Edinb); 1991 Jan; 49(1):97-105. PubMed ID: 1938381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
    Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
    Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group.
    Aitchison TC; Sirel JM; Watt DC; MacKie RM
    BMJ; 1995 Dec; 311(7019):1536-9; discussion 1539-41. PubMed ID: 8520396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary multiple malignant neoplasms in patients with skin melanoma].
    Korovin SI; Gulak LO; Fedorenko ZP; Gordienko TV; Kukushkina MN
    Lik Sprava; 2008; (3-4):63-71. PubMed ID: 19145823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
    MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
    BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
    Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
    J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in patients with multiple primary melanomas: Systematic review and meta-analysis.
    Peek G; Olsen CM; Baade P; Youlden DR; Aitken JF; Green AC; Khosrotehrani K
    J Am Acad Dermatol; 2020 Nov; 83(5):1406-1414. PubMed ID: 32246965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational study of type of surgical training and outcome of definitive surgery for primary malignant melanoma.
    MacKie RM; Bray CA; Hole DJ
    BMJ; 2002 Nov; 325(7375):1276-7. PubMed ID: 12458246
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing incidence and mortality from cutaneous malignant melanoma.
    Melia J
    BMJ; 1997 Nov; 315(7116):1106-7. PubMed ID: 9374878
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of patients with de novo versus nevus-associated melanoma.
    Lin WM; Luo S; Muzikansky A; Lobo AZ; Tanabe KK; Sober AJ; Cosimi AB; Tsao H; Duncan LM
    J Am Acad Dermatol; 2015 Jan; 72(1):54-8. PubMed ID: 25440436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
    Dalmasso B; Pastorino L; Ciccarese G; Andreotti V; Grillo F; Mastracci L; Spagnolo F; Ballestrero A; Queirolo P; Bruno W; Ghiorzo P
    J Am Acad Dermatol; 2019 May; 80(5):1263-1271. PubMed ID: 30274933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing survival in melanoma.
    Rigel DS; Friedman RJ; Kopf AW; Silverman MK
    Dermatol Clin; 1991 Oct; 9(4):631-42. PubMed ID: 1934638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant melanoma of the female genitalia. 4].
    Hempel J; Remmele W
    Z Hautkr; 1973 Oct; 48(19):791-800. PubMed ID: 4766873
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis of malignant melanoma.
    Rigel DS; Rogers GS; Friedman RJ
    Dermatol Clin; 1985 Apr; 3(2):309-14. PubMed ID: 3830493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.